K
K.C. Srivastava
Researcher at Odense University
Publications - 11
Citations - 1225
K.C. Srivastava is an academic researcher from Odense University. The author has contributed to research in topics: Thromboxane B2 & Thromboxane. The author has an hindex of 10, co-authored 11 publications receiving 1159 citations.
Papers
More filters
Journal ArticleDOI
Effect of ginger (Zingiber officinale Rosc.) and fenugreek (Trigonella foenumgraecum L.) on blood lipids', blood sugar and platelet aggregation in patients with coronary artery disease
TL;DR: In patients with CAD powdered ginger administered in a dose of 4 g daily for 3 months did not affect ADP- and epinephrine-induced platelet aggregation, and no change in the fibrinolytic activity and fibrinogen level was observed.
Journal ArticleDOI
Effect of garlic (Allium sativum) on blood lipids, blood sugar, fibrinogen and fibrinolytic activity in patients with coronary artery disease
TL;DR: Two important paraffinic polysulphides derived from garlic and are usual constituents of garlic oil, showed antiplatelet activity, and also inhibited platelet thromboxane formation, and DATS was more potent than DADS.
Journal ArticleDOI
Curcumin, a major component of food spice turmeric (Curcuma longa) inhibits aggregation and alters eicosanoid metabolism in human blood platelets
TL;DR: Curcumin's anti-inflammatory property may, in part, be explained by its effects on eicosanoid biosynthesis.
Journal ArticleDOI
Effects of a garlic-derived principle (ajoene) on aggregation and arachidonic acid metabolism in human blood platelets.
K.C. Srivastava,O.D. Tyagi +1 more
TL;DR: Ajoene was found to inhibit platelet aggregation induced by AA, adrenaline, collagen, adenosine diphosphate (ADP) and calcium ionophore A23187; the nature of the inhibition was irreversible.
Journal ArticleDOI
Effect of onion and ginger consumption on platelet thromboxane production in humans
TL;DR: The effects of onion and ginger consumption on platelet thromboxane production were examined and TxB2 determination was made in serum obtained after blood clotting.